Prevalence of MetS and its components in patients with SLE
| SLE cohort (n=116) | |
| MetS, n (%) | 34 (29) |
| Blood pressure | |
| Arterial hypertension, n (%) | 68 (59) |
| Systolic, median (Q1, Q3) | 120.5 (113, 134) |
| Diastolic, median (Q1, Q3) | 72 (64, 79) |
| Obesity | |
| BMI >30, n (%) | 19 (16) |
| BMI, median (Q1, Q3) | 23.5 (21.3, 27.8) |
| Hypertriglyceridaemia | |
| n (%) | 37 (32) |
| Fasting triglyceride, median (Q1, Q3) | 0.8 (0.6, 1.0) |
| Low HDL | |
| n (%) | 59 (51) |
| Fasting HDL, median (Q1, Q3) | 1.4 (1.1, 1.8) |
| Hyperglycaemic | |
| n (%) | 26 (22) |
| Fasting glucose, median (Q1, Q3) | 4.7 (4.4, 5.2) |
Data are n (%) or median (Q1, Q3).
BMI, body mass index; HDL, high-density lipoprotein; MetS, metabolic syndrome.